MOLECULAR PARTNERS AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.36 CHF | +5.00% |
|
-0.30% | -2.33% |
| Mar. 15 | Transcript : Molecular Partners AG, 2023 Earnings Call, Mar 15, 2024 | |
| Mar. 15 | Molecular Partners Swings to Loss in FY23; Revenue Down | MT |
Quotes 5-day view
Delayed Quote Swiss Exchange| 2024-04-23 | 2024-04-24 | 2024-04-25 | 2024-04-26 | |
|---|---|---|---|---|
| Last | 3.415 CHF | 3.26 CHF | 3.2 CHF | 3.36 CHF |
| Volume | 3 527 | 3 428 | 20 118 | 3 521 |
| Change | +3.48% | -4.54% | -1.84% | +5.00% |
| Opening | 3.28 | 3.26 | 3.27 | 3.19 |
| High | 3.45 | 3.51 | 3.36 | 3.36 |
| Low | 3.25 | 3.25 | 3.20 | 3.19 |
Performance
| 1 day | +5.00% | ||
| 1 week | -0.30% | ||
| Current month | -8.57% | ||
| 1 month | -11.58% | ||
| 3 months | -16.00% | ||
| 6 months | +2.13% | ||
| Current year | -2.33% | ||
| 1 year | -41.77% | ||
| 3 years | -85.33% | ||
| 5 years | -81.27% |
Volumes
marketsDaily volume
3 521
Estimated daily volume
3 521
Avg. Volume 20 sessions
8 705
Daily volume ratio
0.40
Avg. Volume 20 sessions CHF
29 248.80
Avg. Volume 20 sessions USD
31 980.64
Record volume 1
1 849 871
Record volume 2
1 365 978
Record volume 3
1 014 863
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (CHF)
110 422 408
Capitalization (USD)
120 735 861
Net sales (CHF)
7 000 000
Net sales (USD)
7 653 800
Number of employees
168
Sales / Employee (CHF)
41 667
Sales / Employee (USD)
45 558
Free-Float
81.11 %
Free-Float capitalization (CHF)
99 094 860
Free-Float capitalization (USD)
108 350 320
Average Daily Capital Traded
0.03%
Highs and lows
1 week
3.19
3.51
1 month
3.193.77
Current year
3.194.57
1 year
3.046.30
3 years
3.0428.90
5 years
3.0428.90
10 years
3.0438.75
Indicators
Moving average 5 days
3.31
Moving average 20 days
3.46
Moving average 50 days
3.62
Moving average 100 days
3.76
Price spread / (MMA5)
-1.58%
Price spread / (MMA20)
+2.88%
Price spread / (MMA50)
+7.63%
Price spread / (MMA100)
+11.86%
STIM
RSI 9 days
34.72
RSI 14 days
38.18
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +5.00% | -0.30% | -2.33% | -41.77% | 121M | ||
| -0.06% | +0.81% | -2.31% | +22.94% | 103B | ||
| -0.84% | -1.52% | +0.56% | +13.52% | 95.28B | ||
| +0.90% | +3.56% | +1.69% | +0.60% | 22.15B | ||
| +0.58% | +0.46% | -17.37% | -21.15% | 21.02B | ||
| +2.04% | -2.57% | -9.30% | -29.49% | 18.15B | ||
| +3.17% | +1.71% | -41.01% | -37.19% | 16.74B | ||
| +3.38% | +18.58% | -14.85% | -37.58% | 16.05B | ||
| -1.28% | +3.02% | +3.21% | +32.39% | 13.68B | ||
| +1.08% | +11.37% | +33.54% | +5.31% | 12.17B | ||
| +1.98% | -1.93% | -24.71% | -33.33% | 8.24B | ||
| -0.75% | -3.05% | +7.90% | +77.79% | 7.76B | ||
| +0.95% | +0.62% | +0.17% | +51.30% | 7.71B | ||
| +7.91% | +17.17% | +299.30% | +280.10% | 8.19B | ||
| +0.72% | +5.24% | -1.21% | +28.46% | 6.99B | ||
| +0.83% | -3.27% | -21.74% | +75.93% | 6.85B | ||
| Average | +1.13% | +3.13% | +13.22% | +24.24% | ||
| Weighted average by Cap. | +0.33% | +1.68% | +2.75% | +15.65% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
7a129d9a85eb37.bT2cl_UjVMPPbVGyd3_5qu-u4OW_J_hOJ6i0rDT9BpE.CmT_-5IRJo-tDBWHFQis44DGoqPOYs8JV-XSwnO5TtAdXurah2o_kPcqJg
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 11:31:30 am | 3.36 | 1 | 3,521 |
| 11:31:30 am | 3.36 | 1,246 | 3,520 |
| 11:31:30 am | 3.36 | 22 | 2,274 |
| 11:31:30 am | 3.36 | 22 | 2,252 |
| 11:31:30 am | 3.36 | 22 | 2,230 |
| 11:31:30 am | 3.36 | 448 | 2,208 |
| 11:31:30 am | 3.36 | 171 | 1,760 |
| 11:31:30 am | 3.36 | 94 | 1,589 |
| 11:31:30 am | 3.36 | 203 | 1,495 |
| 11:31:30 am | 3.36 | 171 | 1,292 |
Monthly variations
Annual change
| 2024 | -2.33% | ||
| 2023 | -44.16% | ||
| 2022 | -65.43% | ||
| 2021 | -14.12% | ||
| 2020 | +18.44% | ||
| 2019 | -8.08% | ||
| 2018 | -27.53% | ||
| 2017 | +6.05% | ||
| 2016 | -29.14% | ||
| 2015 | +39.17% | ||
| 2014 | +12.28% |
- Stock Market
- Equities
- MOLN Stock
- Quotes Molecular Partners AG
